Related Experiment Video
Updated: May 30, 2025

A Preclinical Model of Exertional Heat Stroke in Mice
Published on: July 1, 2021
Potential Cisatracurium-Induced Malignant Hyperthermia: A Case Report.
Sinen Zeleke1, Victoria L Watson1, Catherine Adams2
1Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Malignant hyperthermia, a rare pharmacogenetic disorder, can be triggered by nondepolarizing neuromuscular blockers like cisatracurium. This case highlights the importance of considering this rare cause of hypermetabolic crisis for prompt dantrolene administration.
Area of Science:
- Pharmacogenetics
- Anesthesiology
- Critical Care Medicine
Background:
- Malignant hyperthermia is a life-threatening pharmacogenetic disorder.
- It is typically associated with depolarizing neuromuscular blocking agents.
- Cases linked to nondepolarizing agents are infrequently documented.
More Related Videos
06:43Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Increased Body Temperature
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...